Compounds with (perfluoroalkyl) fluorohydrogenphosphate anions

ABSTRACT

The present invention relates to a process for the preparation of compounds with (perfluoroalkyl)fluorohydrogenphosphate anion, and to compounds containing (perfluoroalkyl)fluorohydrogenphosphate anion and to the use thereof.

The present invention relates to a process for the preparation of compounds with (perfluoroalkyl)fluorohydrogenphosphate anion, and to compounds with (perfluoroalkyl)fluorohydrogenphosphate anion and to the use thereof.

Onium salts with perfluoroalkylfluorophosphate anions (FAP anions) are employed as ionic liquids and conductive salts [EP 0929558 B1, WO 02/085919 A1, EP 1162204 A1].

An ionic liquid is taken to mean salts which generally consist of an organic cation and an inorganic anion. They do not contain any neutral molecules and usually have melting points below 373 K [Wasserscheid P, Keim W, 2000, Angew. Chem. 112: 3926].

Onium salts with an organic cation and a perfluoroalkylfluorophosphate anion (FAP anion) are usually prepared via an exchange reaction of a water-soluble onium salt with, for example, a chloride, bromide, tetra-fluoroborate or triflate anion and perfluoroalkylfluorophosphoric acid (HFAP) or its alkali-metal salts in water [N. V. Ignatyev, U. Welz-Biermann, A. Kucheryna, G. Bissky, H. Willner, 2005, J. Fluorine Chem. 126: 1150-1159]. HFAP [WO 03/002579] and metal salts thereof can be prepared from tris(perfluoroalkyl)difluorophosphoranes, which can be obtained by electrochemical fluorination (Simons process) of trialkylphosphines [N. V. Ignatyev, P. Sartori, 2000, J. Fluorine Chem. 103: 57-61; WO 00/21969]. Organic salts with an FAP anion usually have limited water solubility and can easily be separated from by-products, which remain in the aqueous solution.

Ionic liquids with FAP anion have high electrochemical and thermal stability and low viscosity. Areas of application of these ionic liquids are found in organic chemistry (solvents, extraction media, etc.) and in the material sciences (heat-exchange media, lubricants, conductive salts, etc.). Ionic liquids having FAP anions are inert materials which have much better hydrolytic stability than, for example, ionic liquids having PF₆ ⁻ anions. In some cases, however, a medium is desirable which can easily be broken down again after the respective process.

The aim of the present invention was thus firstly the provision of a novel process for the preparation of compounds containing (perfluoroalkyl)fluorohydrogenphosphate anions. A further aim of the present invention was the provision of novel compounds containing (perfluoroalkyl)fluorohydrogenphosphate anions.

WO 03/087113 discloses a process which facilitates the reduction of (perfluoroalkyl)fluorophosphoranes. Surprisingly, a process has now been found which facilitates the addition of a hydride ion onto the substrate during the reaction of (perfluoroalkyl)fluorophosphorane with a hydride ion donor, giving a (perfluoroalkyl)fluorohydrogenphosphate anion.

The present invention thus relates firstly to a process for the preparation of a compound of the formula (1) [Kt]^(x+)[(C_(n)F_(2n+1))_(z)PF_(5-z)H]⁻ _(x)  (1)

in which [Kt]^(x+) is an inorganic or organic cation,

where, in one step, a compound of the formula (2) (C_(n)F_(2n+1))_(z)PF_(5-z)  (2)

is reacted with a hydride ion donor,

and where, if [Kt]^(x+) is an organic cation, a second step can optionally be carried out in which the product from the first step is reacted with a compound of the formula (3) [Kt]^(x+)[X]⁻ _(X)  (3),

in which [Kt]^(x+) stands for an organic cation and [X]⁻ stands for a hydrophilic anion,

in which n=1-8, x=1-4 and z=1-4.

In the literature, bis(trifluoromethyl)difluorohydrogenphosphate ([(CF₃)₂PF₃H]⁻) and trifluoromethyltrifluorohydrogenphosphate ([CF₃PF₄H]⁻) salts with K⁺ cation and [Me₂NH₂]⁺ cation are described [J. F. Nixon, J. R. Swain, 1968, Chem. Comm.: 997-998; J. F. Nixon, J. R. Swain, 1970, J. Chem. Soc. A: Inorg. Phys. Theor.: 2075-2080; R. G. Cavell, J. F. Nixon, 1964, Proc. Chem. Soc.: 229]. K⁺ [(CF₃)₂PF₃H]⁻ and K⁺ [CF₃PF₄H]⁻ salts are prepared in situ in a reaction of bis(trifluoromethyl)fluorophosphine ((CF₃)₂PF) or trifluoromethyldifluorophosphine (CF₃PF₂) with potassium bifluoride in a sealed test tube at 60 to 100° C. or in acetonitrile solution at room temperature. The corresponding salts with a [Me₂NH₂]⁺ cation are obtained by the reaction of CF₃PF₂ or (CF₃)₂PF with Me₂NH.

These salts have merely been investigated with the aid of ¹⁹F- and ¹H-NMR spectroscopic measurements in the reaction mixture. For the synthesis of [(CF₃)₂PF₃H]⁻ and [CF₃PF₄H]⁻ salts by the method of J. F. Nixon and J. R. Swain, the two starting materials bis(trifluoromethyl)fluorophosphine (CF₃)₂PF and trifluoromethyldifluorophosphine CF₃PF₂, which are in the gaseous state at room temperature and are highly air-sensitive, are necessary. These can be prepared in a complex, multistep synthesis process.

In accordance with the invention, hydride ion donors are compounds which are capable of releasing one or more hydride ions (H⁻). In the process according to the invention, the hydride ion donor is preferably selected from the group comprising metal hydrides, borohydrides, hydridoborates and hydridoaluminates, but also tertiary and secondary amines.

In a particularly preferred embodiment, metal hydrides are employed; these are very particularly preferably LiAlH₄.

In a further particularly preferred embodiment, use is made of tertiary or secondary amines of the formula (11): R¹⁴ ₂N—CH₂R¹⁵  (11),

where

R¹⁴ and R¹⁵ on each occurrence, independently of one another, denotes

-   -   H, where a maximum of one substituent R¹⁴ can be H,     -   straight-chain or branched alkyl having 1-20 C atoms,     -   straight-chain or branched alkenyl having 2-20 C atoms and one         or more double bonds,     -   straight-chain or branched alkynyl having 2-20 C atoms and one         or more triple bonds,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,

where R¹⁵ may also be Cl or F,

where R¹⁵ may be fully substituted by fluorine and/or one or more R¹⁴ and/or R¹⁵ may be partially substituted by halogens or partially substituted by —OR^(1*), —NR^(1*) ₂, —CN, —C(O)NR^(1*) ₂ or —SO₂NR^(1*) ₂,

and where one or two non-adjacent carbon atoms which are not in the α-position of the radicals R¹⁴ and/or R₁₅ may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO₂—, —N⁺R^(1*) ₂—, —C(O)NR^(1*)—, —SO₂NR^(1*)— or —P(O)R^(1*)—;

in which R^(1*) stands for non- or partially fluorinated C₁- to C₆-alkyl, C₃- to C₇-cycloalkyl, unsubstituted or substituted phenyl.

The hydride ion donor used after the process according to the invention can be employed either in excess or in equimolar amount, in each case based on the amount of (perfluoroalkyl)fluorophosphoranes employed. The hydride ion donor is preferably employed in equimolar amount.

(Perfluoroalkyl)fluorophosphoranes of the formula (2) can be prepared by conventional methods known to the person skilled in the art. These compounds are preferably prepared by electrochemical fluorination of suitable starting compounds [V. Y. Semenii et al., 1985, Zh. Obshch. Khim. 55 (12): 2716-2720; N. V. Ignatyev, P. Sartori, 2000, J. Fluorine Chem. 103: 57-61; WO 00/21969].

In the compound of the formula (2), z preferably stands for 2 or 3; this means that formula (2) is preferably selected from the group comprising (C_(n)F_(2n+1))₃PF₂ and (C_(n)F_(2n+1))₂PF₃. z is particularly preferably =3.

In the compounds of the formula (2), n likewise preferably stands for 2, 3 or 4, particularly preferably for 2 or 4. n very particularly preferably stands for 2, this means that a compound of the formula (2) is very particularly preferably (C₂F₅)_(z)PF_(5-z).

The compounds of the formula (2) are thus very particularly preferably (C₂F₅)₃PF₂.

The cation [Kt]^(x+) in formula (1) of the process according to the invention can be either an inorganic cation or an organic cation.

If an inorganic cation is present, this is preferably a metal cation. The metal cation is particularly preferably an alkali-metal cation, preferably a lithium, sodium or potassium cation.

If [Kt]^(x+) in formula (1) is an organic cation, this is preferably selected, exactly like [Kt]^(x+) in formula (3), from the group comprising ammonium, phosphonium, uronium, thiouronium, sulfonium, oxonium, guanidinium cations, heterocyclic cations and iminium cations, as defined below:

Ammonium cations are given by the general formula (4) [NR₄]⁺  (4),

where

R in each case, independently of one another, denotes

-   -   H,     -   straight-chain or branched alkyl having 1-20 C atoms,     -   straight-chain or branched alkenyl having 2-20 C atoms and one         or more double bonds,     -   straight-chain or branched alkynyl having 2-20 C atoms and one         or more triple bonds,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,

where one R may be fully substituted by fluorine and/or one or more R may be partially substituted by halogens, in particular —F and/or Cl, or partially substituted by —OR¹, —NR^(1*) ₂, —CN, —C(O)NR¹ ₂ or —SO₂NR¹ ₂,

and where one or two non-adjacent carbon atoms which are not in the α-position of the radical R may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹— or —P(O)R¹—.

Phosphonium cations are given by the general formula (5) [PR² ₄]⁺  (5),

where

R² in each case, independently of one another, denotes

-   -   H where all substituents R² cannot simultaneously be H, NR¹ ₂,     -   straight-chain or branched alkyl having 1-20 C atoms,     -   straight-chain or branched alkenyl having 2-20 C atoms and one         or more double bonds,     -   straight-chain or branched alkynyl having 2-20 C atoms and one         or more triple bonds,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,

where one R² may be fully substituted by fluorine and/or one or more R² may be partially substituted by halogens, in particular —F and/or —Cl, or partially substituted by —OR¹, —CN, —C(O)NR¹ ₂ or —SO₂NR¹ ₂,

and where one or two non-adjacent carbon atoms which are not in the α-position of the R², may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, or —P(O)R¹—.

Cations of the formulae (4) and (5) in which all four or three substituents R and R² are fully substituted by halogens, for example the tris(trifluoromethyl)methylammonium cation, the tetra(trifluoromethyl)ammonium cation or the tetra(nonafluorobutyl)ammonium cation, are therefore excluded.

Uronium cations are given by the general formula (6) [C(NR³R⁴)(OR⁵)(NR⁶R⁷)]⁺  (6)

and suitable thiouronium cations are given by the formula (7), [C(NR³R⁴)(SR⁵)(NR⁶R⁷)]⁺  (7),

where

R³ to R⁷ each, independently of one another, denote

-   -   H, NR^(1*) ₂,     -   straight-chain or branched alkyl having 1 to 20 C atoms,     -   straight-chain or branched alkenyl having 2-20 C atoms and one         or more double bonds,     -   straight-chain or branched alkynyl having 2-20 C atoms and one         or more triple bonds,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,

where one or more of the substituents R³ to R⁷ may be partially substituted by halogens, in particular —F, or by —OH, —OR¹, —CN, —C(O)NR¹ ₂ or —SO₂NR¹ ₂,

and where one or two non-adjacent carbon atoms which are not in the α-position of R³ to R⁷ may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, or —P(O)R¹—.

Sulfonium cations are given by the general formula (12)) [(R^(o))₃S]⁺  (12),

where

R^(o) stands for

-   -   NR^(′″) ₂,     -   straight-chain or branched alkyl having 1-8 C atoms,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,

where one or more of the substituents R⁰ may be partially substituted by halogens, in particular —F, or by —OR^(′″), —CN or —N(R^(′″))₂.

Oxonium cations are given by the general formula (13) [(R^(o) ⁺ )₃O]⁺  (13),

where

R^(o*) stands for

-   -   straight-chain or branched alkyl having 1-8 C atoms,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,         -   where one or more of the substituents R^(0*) may be             partially substituted by halogens, in particular —F, or by             —OR′″, —CN or —N(R^(′″))₂, in which R′″ stands,             independently of one another, for a straight-chain or             branched C₁-C₈-alkyl.

R^(o) and R^(o*) here preferably stand for a straight-chain alkyl having 1-8 C atoms, unsubstituted phenyl, or phenyl which is substituted by C₁-C₆-alkyl, OR^(′″), N(R^(′″))₂, CN or F.

R′″ preferably stands for a straight-chain alkyl having 1-8 C atoms, in particular methyl or ethyl.

Guanidinium cations are given by the general formula (8) [C(NR⁸R⁹)(NR¹⁰R¹¹)(NR¹²R¹³)]⁺  (8),

where

R⁸ to R¹³ each, independently of one another, denote

-   -   H, NR^(1*) ₂,     -   straight-chain or branched alkyl having 1 to 20 C atoms,     -   straight-chain or branched alkenyl having 2-20 C atoms and one         or more double bonds,     -   straight-chain or branched alkynyl having 2-20 C atoms and one         or more triple bonds,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,

where one or more of the substituents R⁸ to R¹³ may be partially substituted by halogens, in particular —F, or by —OR¹, —CN, —C(O)NR¹ ₂ or —SO₂NR¹ ₂, and where one or two non-adjacent carbon atoms which are not in the α-position of R⁸ to R¹³ may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, or —P(O)R¹—.

Heterocyclic cations are given by the general formula (9) [HetN]⁺  (9),

where [HetN]⁺ is a heterocyclic cation selected from the group comprising

where the substituents R^(1′) to R^(4′) each, independently of one another, denote

-   -   H,     -   straight-chain or branched alkyl having 1-20 C atoms,     -   straight-chain or branched alkenyl having 2-20 C atoms and one         or more double bonds,     -   straight-chain or branched alkynyl having 2-20 C atoms and one         or more triple bonds,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,     -   saturated, partially or fully unsaturated heteroaryl,         heteroaryl-C₁-C₆-alkyl or aryl-C₁-C₆-alkyl,

where the substituents R^(1′), R^(2′), R^(3′) and/or R^(4′) together may form a ring system,

where one or more substituents R^(1′) to R^(4′) may be partially or fully substituted by halogens, in particular —F and/or —Cl, or partially substituted by —OR¹, —CN, —C(O)NR¹ ₂ or —SO₂NR¹ ₂, but where R^(1′) and R^(4′) cannot simultaneously be fully substituted by halogens, and where one or two non-adjacent carbon atoms which are not bonded to the heteroatom of the substituents R^(1′) to R^(4′), may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, or —P(O)R¹—.

Iminium cations are given by the general formula (10) [R¹⁴ ₂N═CHR¹⁵]⁺  (10),

where

R¹⁴ and R¹⁵ on each occurrence, independently of one another, denotes

-   -   H, where a maximum of one substituent R¹⁴ can be H,     -   straight-chain or branched alkyl having 1-20 C atoms,     -   straight-chain or branched alkenyl having 2-20 C atoms and one         or more double bonds,     -   straight-chain or branched alkynyl having 2-20 C atoms and one         or more triple bonds,     -   saturated, partially or fully unsaturated cycloalkyl having 3-7         C atoms, which may be substituted by alkyl groups having 1-6 C         atoms,

where R¹⁵ may also stand for Cl or F,

where R¹⁵ may be fully substituted by fluorine and/or one or more R¹⁴ and/or R¹⁵ may be partially substituted by halogens or partially substituted by —OR^(1*), —NR^(1*) ₂, —CN, —C(O)NR^(1*) ₂ or —SO₂NR^(1*) ₂,

and where one or two non-adjacent carbon atoms which are not in the α-position of the radical R¹⁴ and/or R¹⁵ may be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO₂—, —N⁺R^(1*) ₂—, —C(O)NR^(1*)—, —SO₂NR^(1*)— or —P(O)R^(1*)—;

R¹ in all above-mentioned definitions stands for H, non- or partially fluorinated C₁- to C₆-alkyl, C₃- to C₇-cycloalkyl, unsubstituted or substituted phenyl, and R^(1*)stands for non- or partially fluorinated C₁- to C₆-alkyl, C₃- to C₇-cycloalkyl, unsubstituted or substituted phenyl.

Fully unsaturated cycloalkyl substituents in the sense of the present invention are also taken to mean aromatic substituents.

In accordance with the invention, suitable substituents R and R² to R¹³ of the compounds of the formulae (4) to (8), besides H, are preferably: C₁- to C₂₀—, in particular C₁- to C₁₄-alkyl groups, and saturated or unsaturated, i.e. also phenyl, C₃- to C₇-cycloalkyl groups, which may be substituted by C₁- to C₆-alkyl groups, in particular phenyl.

The substituents R and R² in the compounds of the formula (4) or (5) may be identical or different. In compounds of the formulae (4), three or four substituents R are preferably identical. In compounds of the formulae (5), the substituents R² are preferably different.

The substituents R and R² are particularly preferably methyl, ethyl, isopropyl, propyl, butyl, sec-butyl, pentyl, hexyl, octyl, decyl or tetradecyl.

Up to four substituents of the guanidinium cation

[C(NR⁸R⁹)(NR¹⁰R¹¹)(NR¹²R¹³)]⁺ may also be connected in pairs in such a way that mono-, bi- or polycyclic molecules form.

Without restricting generality, examples of such guanidinium cations are:

where the substituents R⁸ to R¹⁰ and R¹³ may have an above-mentioned or particularly preferred meaning.

The carbocycles or heterocycles of the above-mentioned guanidinium cations may optionally also be substituted by C₁- to C₆-alkyl, C₁- to C₆-alkenyl, CN, NR¹ ₂, F, Cl, Br, I, C₁-C₆-alkoxy, SCF₃, SO₂CF₃ or SO₂NR¹ ₂, where R¹ has an above-mentioned meaning, substituted or unsubstituted phenyl or unsubstituted or substituted heterocycle.

Up to four substituents of the thiouronium cation [C(NR³R⁴)(SR⁵)(NR⁶R⁷)]⁺ may also be connected in pairs in such a way that mono-, bi- or polycyclic molecules form.

Without restricting generality, examples of such thiouronium cations are indicated below:

in which Y═S

and where the substituents R³, R⁵ and R⁶ may have an above-mentioned or particularly preferred meaning.

The carbocycles or heterocycles of the above-mentioned molecules may optionally also be substituted by C₁- to C₆-alkyl, C₁- to C₆-alkenyl, CN, NR¹ ₂, F, Cl, Br, I, C₁-C₆-alkoxy, SCF₃, SO₂CF₃ or SO₂NR¹ ₂ or substituted or unsubstituted phenyl or unsubstituted or substituted heterocycle, where R¹ has an above-mentioned meaning.

The substituents R³ to R¹³ are each, independently of one another, preferably a straight-chain or branched alkyl group having 1 to 10 C atoms. The substituents R³ and R⁴, R⁶ and R⁷, R⁸ and R⁹, R¹⁰ and R¹¹ and R¹² and R¹³ in compounds of the formulae (7) and (8) may be identical or different. R³ to R¹³ are particularly preferably each, independently of one another, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, sec-butyl, phenyl or cyclohexyl, very particularly preferably methyl, ethyl, n-propyl, isopropyl or n-butyl.

In accordance with the invention, suitable substituents R^(1′) to R^(4′) of compounds of the formula (9), besides H, are preferably: C₁- to C₂₀, in particular C₁- to C₁₂-alkyl groups, and saturated or unsaturated, i.e. also aromatic, C₃- to C₇-cycloalkyl groups, which may be substituted by C₁- to C₆-alkyl groups, in particular phenyl.

The substituents R^(1′) and R^(4′) are each, independently of one another, particularly preferably methyl, ethyl, isopropyl, propyl, butyl, sec-butyl, pentyl, hexyl, octyl, decyl, cyclohexyl, phenyl or benzyl. They are very particularly preferably methyl, ethyl, n-butyl or hexyl. In pyrrolidine, piperidine, indoline, pyrrolidinium, piperidinium or indolinium compounds, the two substituents R^(1′) and R^(4′) are preferably different.

The substituent R^(2′) or R^(3′) is in each case, independently of one another, in particular H, methyl, ethyl, isopropyl, propyl, butyl, sec-butyl, tert-butyl, cyclohexyl, phenyl or benzyl. R^(2′) is particularly preferably H, methyl, ethyl, isopropyl, propyl, butyl or sec-butyl. R^(2′) and R^(3′) are very particularly preferably H.

The C₁-C₁₂-alkyl group is, for example, methyl, ethyl, isopropyl, propyl, butyl, sec-butyl or tert-butyl, furthermore also pentyl, 1-, 2- or 3-methylbutyl, 1,1-, 1,2- or 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl or dodecyl. Optionally difluoromethyl, trifluoromethyl, pentafluoroethyl, heptafluoropropyl or nonafluorobutyl.

In accordance with the invention suitable substituents R¹⁴ and R¹⁵ of the compounds of the formulae (10) and (11), besides H, are preferably: C₁- to C₂₀—, particularly preferably C₁- to C₁₄-alkyl groups and very particularly preferably C₁- to C₄-alkyl groups, which may in each case be unbranched or branched and where one or more radicals R¹⁴ may be substituted by —NR^(1*) ₂.

The substituents —R¹⁴ and —CH₂—R¹⁵ here may be identical or different. In a preferred embodiment, all three substituents —R¹⁴ and —CH₂—R¹⁵ are identical. In a further preferred embodiment, two of the substituents —R¹⁴ and —CH₂—R¹⁵ are identical.

The substituents R¹⁴ are particularly preferably H, methyl, ethyl, isopropyl or dimethylaminomethyl.

The substituents R¹⁵ are particularly preferably H or methyl.

The compound of the formula (11) is preferably selected from the compounds of the formula N(CH₃)₃, N(C₂H₅)₃, HN(C₂H₅)₂, (CH₃)₂N—CH₂—N(CH₃)₂ or CH₃N((CH(CH₃)₂)₂.

A straight-chain or branched alkenyl having 2 to 20 C atoms, where, in addition, a plurality of double bonds may be present, is, for example, allyl, 2- or 3-butenyl, isobutenyl, sec-butenyl, furthermore 4-pentenyl, isopentenyl, hexenyl, heptenyl, octenyl, —C₉H₁₇, —C₁₀H₁₉ to —C₂₀H₃₉; preferably allyl, 2- or 3-butenyl, isobutenyl, sec-butenyl, preference is furthermore given to 4-pentenyl, isopentenyl or hexenyl.

A straight-chain or branched alkynyl having 2 to 20 C atoms, where, in addition, a plurality of triple bonds may be present, is, for example, ethynyl, 1- or 2-propynyl, 2- or 3-butynyl, furthermore 4-pentynyl, 3-pentynyl, hexynyl, heptynyl, octynyl, —C₉H₁₅, —C₁₀H₁₇ to —C₂₀H₃₇, preferably ethynyl, 1- or 2-propynyl, 2- or 3-butynyl, 4-pentynyl, 3-pentynyl or hexynyl.

Aryl-C₁-C₆-alkyl denotes, for example, benzyl, phenylethyl, phenylpropyl, phenylbutyl, phenylpentyl or phenylhexyl, where both the phenyl ring and also the alkylene chain may be partially or fully substituted, as described above, by halogens, in particular —F and/or —Cl, or partially substituted by —OR¹, —NR¹ ₂, —CN, —C(O)NR¹ ₂, —SO₂NR¹ ₂.

Unsubstituted saturated or partially or fully unsaturated cycloalkyl groups having 3-7 C atoms are therefore cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentenyl, cyclohexenyl, phenyl, cycloheptenyl, each of which may be substituted by C₁- to C₆-alkyl groups, where the cycloalkyl group or the cycloalkyl group which is substituted by C₁- to C₆-alkyl groups may in turn also be substituted by halogen atoms, such as F, Cl, Br or I, in particular F or Cl, or by —OR¹, —CN, —C(O)NR¹ ₂, —SO₂NR¹ ₂.

In the substituents R, R² to R¹³ or R^(1′) to R^(4′), one or two non-adjacent carbon atoms which are not bonded in the α-position to the heteroatom may also be replaced by atoms and/or atom groups selected from the group —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, or —P(O)R¹—, where R¹=non-, partially or perfluorinated C₁- to C₆-alkyl, C₃- to C₇-cycloalkyl, unsubstituted or substituted phenyl.

Without restricting generality, examples of substituents R, R² to R¹³ and R^(1′) to R^(4′) modified in this way are: —OCH₃, —OCH(CH₃)₂, —CH₂OCH₃, —CH₂—CH₂—O—CH₃, —C₂H₄OCH(CH₃)₂, —C₂H₄SC₂H₅, —C₂H₄SCH(CH₃)₂, —S(O)CH₃, —SO₂CH₃, —SO₂C₆H₅, —SO₂C₃H₇, —SO₂CH(CH₃)₂, —SO₂CH₂CF₃, —CH₂SO₂CH₃, —O—C₄H₈—)—C₄H₉, —CF₃, —C₂F₅, —C₃F₇, —C₄F₉, —C(CF₃)₃, —CF₂SO₂CF₃, —C₂F₄N(C₂F₅)C₂F₅, —CHF₂, —CH₂CF₃, —C₂F₂H₃, —C₃FH₆, —CH₂C₃F₇, —C(CFH₂)₃, —CH₂C₆H₅ or P(O)(C₂H₅)₂.

In R¹, C₃- to C₇-cycloalkyl is, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cycloheptyl.

In R¹, substituted phenyl means phenyl which is substituted by C₁- to C₆-alkyl, C₁- to C₆-alkenyl, CN, NR¹ ₂, F, Cl, Br, I, C₁-C₆-alkoxy, SCF₃, SO₂CF₃ or SO₂NR*₂, where R* denotes a non-, partially or perfluorinated C₁- to C₆-alkyl or C₃- to C₇-cycloalkyl, as defined for R¹, for example, o-, m- or p-methylphenyl, o-, m- or p-ethylphenyl, o-, m- or p-propylphenyl, o-, m- or p-isopropylphenyl, o-, m- or p-tert-butylphenyl, o-, m- or p-methoxyphenyl, o-, m- or p-ethoxyphenyl, o-, m-, p-(trifluoromethyl)phenyl, o-, m-, p-(trifluoromethoxy)phenyl, o-, m-, p-(trifluoromethylsulfonyl)phenyl, o-, m- or p-fluorophenyl, o-, m- or p-chlorophenyl, o-, m- or p-bromophenyl, o-, m- or p-iodophenyl, further preferably 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dimethylphenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dihydroxyphenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-difluorophenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dichloro-phenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dibromophenyl, 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dimethoxyphenyl, 5-fluoro-2-methylphenyl, 3,4,5-trimethoxyphenyl or 2,4,5-trimethylphenyl.

In R^(1′) to R^(4′), heteroaryl is taken to mean a saturated or unsaturated mono- or bicyclic heterocyclic radical having 5 to 13 ring members, where 1, 2 or 3 N and/or 1 or 2 S or O atoms may be present and the heterocyclic radical may be mono- or polysubstituted by C₁- to C₆-alkyl, C₁- to C₆-alkenyl, CN, NR¹ ₂,F, Cl, Br, I, C₁-C₆-alkoxy, SCF₃, SO₂CF₃ or SO₂NR¹ ₂, where R¹ has a meaning indicated above.

The heterocyclic radical is preferably substituted or unsubstituted 2- or 3-furyl, 2- or 3-thienyl, 1-, 2- or 3-pyrrolyl, 1-, 2-, 4- or 5-imidazolyl, 3-, 4- or 5-pyrazolyl, 2-, 4- or 5-oxazolyl, 3-, 4- or 5-isoxazolyl, 2-, 4- or 5-thiazolyl, 3-, 4- or 5-isothiazolyl, 2-, 3- or 4-pyridyl, 2-, 4-, 5- or 6-pyrimidinyl, furthermore preferably 1,2,3-triazol-1-, -4- or -5-yl, 1,2,4-triazol-1-, -4- or -5-yl, 1- or 5-tetrazolyl, 1,2,3-oxadiazol-4- or -5-yl 1,2,4-oxadiazol-3- or -5-yl, 1,3,4-thiadiazol-2- or -5-yl, 1,2,4-thiadiazol-3- or -5-yl, 1,2,3-thiadiazol-4- or -5-yl, 2-, 3-, 4-, 5- or 6-2H-thiopyranyl, 2-, 3- or 4-4H-thiopyranyl, 3- or 4-pyridazinyl, pyrazinyl, 2-, 3-, 4-, 5-, 6- or 7-benzofuryl, 2-, 3-, 4-, 5-, 6- or 7-benzothienyl, 1-, 2-, 3-, 4-, 5-, 6- or 7-1H-indolyl, 1-, 2-, 4- or 5-benzimidazolyl, 1-, 3-, 4-, 5-, 6- or 7-benzopyrazolyl, 2-, 4-, 5-, 6- or 7-benzoxazolyl, 3-, 4-, 5-, 6- or 7-benzisoxazolyl, 2-, 4-, 5-, 6- or 7-benzothiazolyl, 2-, 4-, 5-, 6- or 7-benzisothiazolyl, 4-, 5-, 6- or 7-benz-2,1,3-oxadiazolyl, 1-, 2-, 3-, 4-, 5-, 6-, 7- or 8-quinolinyl, 1-, 3-, 4-, 5-, 6-, 7- or 8-isoquinolinyl, 1-, 2-, 3-, 4- or 9-carbazolyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-acridinyl, 3-, 4-, 5-, 6-, 7- or 8-cinnolinyl, 2-, 4-, 5-, 6-, 7- or 8-quinazolinyl or 1-, 2- or 3-pyrrolidinyl.

Heteroaryl-C₁-C₆-alkyl is, analogously to aryl-C₁-C₆-alkyl, now taken to mean, for example, pyridinylmethyl, pyridinylethyl, pyridinylpropyl, pyridinylbutyl, pyridinylpentyl, pyridinylhexyl, where, furthermore, the heterocycles described above may be linked to the alkylene chain in this way.

HetN⁺ is preferably

where the substituents R^(1′) to R^(4′) each, independently of one another, have a meaning described above.

The organic cation [Kt]^(x+) is particularly preferably selected from the group comprising imidazolium, pyridinium, pyrrolidinium, ammonium, phosphonium or iminium cations, as defined above.

Particularly suitable imidazolium, pyrrolidinium and ammonium cations are selected from the group tetraalkylammonium, 1,1-dialkylpyrrolidinium, 1-alkyl-1-alkoxyalkylpyrrolidnium or 1,3-dialkylimidazolium, where the alkyl groups or the alkoxy group in the alkoxyalkyl group may each, independently of one another, have 1 to 10 C atoms. Very particularly preferably, the alkly groups have 1 to 6 C atoms and the alkoxy group has 1 to 3 C atoms. The alkyl groups in tetraalkylammonium can therefore be identical or different. Preferably, three alkyl groups are identical and one alkyl group is different or two alkyl groups are identical and the other two are different. Preferred tetraalkylammonium cations are, for example, trimethyl(ethyl)ammonium, triethyl(methyl)ammonium, tripropyl(methyl)ammonium, tributyl(methyl)ammonium, tripentyl(methyl)ammonium, trihexyl(methyl)ammonium, triheptyl(methyl)ammonium, trioctyl(methyl)ammonium, trinonyl(methyl)ammonium, tridecyl(methyl)ammonium, trihexyl(ethyl)ammonium, ethyl(trioctyl)ammonium, propyl(dimethyl)ethylammonium, butyl(dimethyl)-ethylammonium, methoxyethyl(dimethyl)ethylammonium, methoxyethyl(diethyl)methylammonium, methoxyethyl(dimethyl)propylammonium, ethoxyethyl(dimethyl)ethylammonium. Particularly preferred quaternary ammonium cations are propyl(dimethyl)ethylammonium and/or methoxyethyl(dimethyl)ethylammonium.

Preferred 1,1-dialkylpyrrolidinium cations are, for example, 1,1-dimethylpyrrolidinium, 1-methyl-1-ethylpyrrolidinium, 1-methyl-1-propylpyrrolidinium, 1-methyl-1-butylpyrrolidinium, 1-methyl-1-pentylpyrrolidinium, 1-methyl-1-hexylpyrrolidinium, 1-methyl-1-heptylpyrrolidinium, 1-methyl-1-octylpyrrolidinium, 1-methyl-1-nonylpyrrolidinium, 1-methyl-1-decylpyrrolidinium, 1,1-diethylpyrrolidinium, 1-ethyl-1-propylpyrrolidinium, 1-ethyl-1-butylpyrrolidinium, 1-ethyl-1-pentylpyrrolidinium, 1-ethyl-1-hexylpyrrolidinium, 1-ethyl-1-heptylpyrrolidinium, 1-ethyl-1-octylpyrrolidinium, 1-ethyl-1-nonylpyrrolidinium, 1-ethyl-1-decylpyrrolidinium, 1,1-dipropylpyrrolidinium, 1-propyl-1-methylpyrrolidinium, 1-propyl-1-butylpyrrolidinium, 1-propyl-1-pentylpyrrolidinium, 1-propyl-1-hexylpyrrolidinium, 1-propyl-1-heptylpyrrolidinium, 1-propyl-1-octylpyrrolidinium, 1-propyl-1-nonylpyrrolidinium, 1-propyl-1-decylpyrrolidinium, 1,1-dibutylpyrrolidinium, 1-butyl-1-methylpyrrolidinium, 1-butyl-1-pentylpyrrolidinium, 1-butyl-1-hexylpyrrolidinium, 1-butyl-1-heptylpyrrolidinium, 1-butyl-1-octylpyrrolidinium, 1-butyl-1-nonylpyrrolidinium, 1-butyl-1-decylpyrrolidinium, 1,1-dipentylpyrrolidinium, 1-pentyl-1-hexylpyrrolidinium, 1-pentyl-1-heptylpyrrolidinium, 1-pentyl-1-octylpyrrolidinium, 1-pentyl-1-nonylpyrrolidinium, 1-pentyl-1-decylpyrrolidinium, 1,1-dihexylpyrrolidinium, 1-hexyl-1-heptylpyrrolidinium, 1-hexyl-1-octylpyrrolidinium, 1-hexyl-1-nonylpyrrolidinium, 1-hexyl-1-decylpyrrolidinium, 1,1-dihexylpyrrolidinium, 1-hexyl-1-heptylpyrrolidinium, 1-hexyl-1-octylpyrrolidinium, 1-hexyl-1-nonylpyrrolidinium, 1-hexyl-1-decylpyrrolidinium, 1,1-diheptylpyrrolidinium, 1-heptyl-1-octylpyrrolidinium, 1-heptyl-1-nonylpyrrolidinium, 1-heptyl-1-decylpyrrolidinium, 1,1-dioctylpyrrolidinium, 1-octyl-1-nonylpyrrolidinium, 1-octyl-1-decylpyrrolidinium, 1-1-dinonylpyrrolidinium, 1-nony-1-decylpyrrolidinium or 1,1-didecylpyrrolidinium. Very particular preference is given to 1-butyl-1-methylpyrrolidinium or 1-propyl-1-methylpyrrolidinium.

Preferred 1-alkyl-1-alkoxyalkylpyrrolidinium cations are, for example, 1-methoxyethyl-1-methylpyrrolidinium, 1-methoxyethyl-1-ethylpyrrolidinium, 1-methoxyethyl-1-propylpyrrolidinium, 1-methoxyethyl-1-butylpyrrolidinium, 1-ethoxyethyl-1-methylpyrrolidinium, 1-ethoxymethyl-1-methylpyrrolidinium. Very particular preference is given to 1-methoxyethyl-1-methylpyrrolidinium.

Preferred 1,3-dialkylimidazolium cations are, for example, 1-ethyl-3-methylimidazolium, 1-methyl-3-propylimidazolium, 1-butyl-3-methylimidazolium, 1-methyl-3-pentylimidazolium, 1-ethyl-3-propylimidazolium, 1-butyl-3-ethylimidazolium, 1-ethyl-3-pentylimidazolium, 1-butyl-3-propylimidazolium, 1,3-dimethylimidazolium, 1,3-diethylimidazolium, 1,3-dipropypylimidazolium, 1,3-dibutylimidazolium, 1,3-dipentylimidazolium, 1,3-dihexylimidazolium, 1,3-diheptylimidazolium, 1,3-dioctylimidazolium, 1,3-dinonylimidazolium, 1,3-didecylimidazolium, 1-hexyl-3-methylimidazolium, 1-heptyl-3-methylimidazolium, 1-methyl-3-octylimidazolium, 1-methyl-3-nonylimidazolium, 1-decyl-3-methylimidazolium, 1-ethyl-3-hexylimidazolium, 1-ethyl-3-heptylimidazolium, 1-ethyl-3-octylimidazolium, 1-ethyl-3-nonylimidazolium or 1-decyl-3-ethylimidazolium. Particularly preferred cations are 1-ethyl-3-methylimidazolium, 1-butyl-3-methylimidazolium or 1-methyl-3-propylimidazolium.

The organic cation [Kt]^(x+) is very particularly preferably a cation selected from the group comprising 1-ethyl-3-methylimidazolium and 1-butyl-3-methylimidazolium.

In formula (3) of the process according to the invention, [X]⁻ stands for a hydrophilic anion. This is preferably an anion selected from the group comprising Cl⁻, Br⁻, I⁻, sulfate, sulfonate, acetate and BF₄ ⁻.

A further very particularly preferred embodiment of the present invention is a process for the preparation of a compound of the formula (1) as defined above in which [Kt]^(x+) is an iminium cation, where a compound of the formula (2) as defined above is reacted with a tertiary or secondary amine of the formula (11) as defined above. This embodiment has the advantage that a compound of the formula (1) containing the organic iminium cation can be prepared directly in one step without a subsequent metathesis reaction being necessary in a second step. The following reaction scheme illustrates this reaction by way of example:

The iminium salts formed here are very reactive compounds.

For example, these compounds are intermediates in the Vilsmeier-Haack reaction, Ugi reaction, Houben-Hoesch reaction, Duff reaction and Stephen aldehyde synthesis. Iminium salts are, in addition, useful starting compounds for the synthesis of β-oxocarboxylic acid esters and β-diketones [Organikum [Practical Organic Chemistry], WILEY-VCH, 2001, p. 617] or for the synthesis of pyrrolidinium derivatives via a Cope rearrangement and intramolecular Mannich reaction [L. E. Overmann, Acc. Chem. Res., 25 (1992), p. 352-359]. Iminium salts react with alcohols (alcoholates), amines, Grignard reagents, alkyl- and aryllithium compounds, compounds containing active methyl(CH₂) groups, diazoalkanes (for example CH₂N₂) or 1,3-dienes.

Iminium salts are frequently used in the synthesis of amino compounds, quaternary ammonium salts, aldehydes, ketones, heterocyclic compounds or steroids [Chemical Encyclopaedia (Russ.) Vol 2, p. 418-419, Moscow, 1990].

More recent publications [T. Yamaguchi, et al., Chem and Ind., 1972, p. 380; J. of the Am. Chem. Soc., 126 (2004), p. 5968; J. of the Am. Chem. Soc., 128 (2006), p. 5648; J. of the Am. Chem. Soc., 129 (2007), p. 780; J. of the Am. Chem. Soc., 130 (2008), p. 11005; Tetrahedron, 62 (2006), p. 6312; Org. Letters, 6 (2006), p. 4093; Org. Letters, 10 (2008), p. 1417; Acc. Chem. Res., 42 (2009), p. 335; Angew. Chem. Int. Ed., 49 (2010), p. 3037] show the broad range of applications of iminium salts. The direct synthesis of these salts from tertiary or secondary amines therefore furthermore enables improvement and simplification of the preparation of a multiplicity of compounds.

Thus, for example, intermolecular rearrangements can occur starting from the iminium salts of the formula (1), where [Kt]^(x+) is an iminium cation, obtained in the process according to the invention. Alternatively, the iminium salts can also react further spontaneously with the nucleophilic reagents, which is depicted by way of example in the following reaction scheme:

In accordance with the invention, the reaction in the first step of the process according to the invention can be carried out at −80 to 50° C. The reaction in the first step is preferably carried out at −20 to 25° C. A temperature of 0° C. is particularly preferred.

The choice of a suitable temperature for the reaction is of particular importance here in order that, in contrast to the reaction disclosed in WO 03/087113, no reduction of the substrate occurs, but instead the addition of a hydride ion takes place.

The reaction in the second step of the process according to the invention is preferably carried out at room temperature.

The reaction in the first step of the process according to the invention is preferably carried out in an aprotic solvent, such as, for example, dioxane, tetrahydrofuran, diethyl ether, methyl tert-butyl ether, hexane, cyclohexane, benzene, dichloromethane or dichloroethane. Cyclic or linear ethers, such as tetrahydrofuran, diethyl ether or methyl tert-butyl ether, are particularly preferably employed. The solvent is very particularly preferably tetrahydrofuran.

The reaction in the second step of the process according to the invention is preferably carried out in water or in a mixture of water and organic solvent.

With the aid of the process according to the invention, various salts having (perfluoroalkyl)fluorohydrogenphosphate anions can be prepared in a simple and comfortable manner. The following reaction scheme illustrates the first step of the process according to the invention with reference to the reaction of (perfluoroalkyl)fluorophosphoranes with, for example, LiAlH₄ as hydride ion donor:

The lithium salt obtained in this way, lithium (perfluoroalkyl)fluorohydrogenphosphate (Li[(C_(n)F_(2n+1))_(z)PF_(5-z)H]), is not only of interest for use as conductive salt (such as, for example, in Li ion batteries or in supercapacitors), but can also be used as starting material for the synthesis of various salts having organic cations (ionic liquids). This reaction represents the second step of the process according to the invention and is illustrated below by way of example:

The present invention therefore likewise relates to the use of a compound of the formula (1) in which [Kt]⁺ is an inorganic cation for the preparation of a compound of the formula (1) in which [Kt]⁺ is an organic cation.

For example, ionic liquids can be prepared in this way.

The compounds of the formula (1) in which [Kt]⁺ is an organic cation which have been prepared with the aid of the process according to the invention have a multiplicity of applications:

Thus, owing to their purity, the absent vapour pressure and the high stability as solvent or solvent additive, they are suitable in chemical reactions. The use as solvent additive takes place in combination with other solvents. Furthermore, the ionic liquids according to the invention can be employed as phase-transfer catalysts, heat-exchange media, as surface-active substances, plasticisers, flameproofing agents or as conductive salts. In addition, the ionic liquids according to the invention are suitable as extractants in substance separation processes.

Owing to their electrochemical properties, the ionic liquids according to the invention can be employed, in particular, in electrochemical applications, such as, for example, as electrolyte in batteries, sensors, accumulators, capacitors or as constituent of a solar cell (solvent and/or electrolyte), preferably a dye solar cell or a sensor.

The ionic liquids prepared with the aid of the process according to the invention have modified properties, such as, for example, modified stability, compared with known ionic liquids.

These hydrophobic ionic liquids can be converted (optionally by heating) into hydrophilic ionic liquids having bis(perfluoroalkyl)phosphinate ((C_(n)F_(2n+1))₂P(O)O⁻) or perfluoroalkylphosphonate anion ((C_(n)F_(2n+1))P(O)O₂ ⁻²) using water or caustic lye solution:

Owing to these unusual properties of the compounds according to the invention, different compounds having certain properties can be prepared as required, for example for use in extraction methods. An in situ conversion of hydrophobic ionic liquids into hydrophilic ionic liquids enables the development of a simple isolation method of water-insoluble products subsequent to a synthesis in hydrophobic ionic liquids having (perfluoroalkyl)fluorohydrogenphosphate anion.

A further difference of ionic liquids having (perfluoroalkyl)fluorohydrogenphosphate anions from other ionic liquids is their reduced stability. This can be attributed to the fact that the symmetry of the (perfluoroalkyl)fluorohydrogenphosphate anions is increased compared with the FAP anion. On hydrolysis, bis(perfluoroalkyl)phosphinates or perfluoroalkylphosphonates form, as already depicted with reference to Scheme 3. On continued hydrolysis, phosphates are formed, as depicted below:

Natural products in the form of phosphates (calcium phosphate is usually formed in the environment) are thus ultimately obtained.

The present invention furthermore relates to compounds of the formula (1) [Kt]^(x+)[(C_(n)F_(2n+1))_(z)PF_(5-z)H]⁻ _(x)  (1)

in which [Kt]^(x+) is an inorganic or organic cation,

where n=1-8, x=1-4 and z=1-4,

where the compounds [(CF₃)₂PF₃H]⁻K⁺, [(CF₃)₂PF₃H]⁻[(CH₃)₂NH₂]⁺, [(CF₃)PF₄H]⁻K⁺ and [(CF₃)PF₄H]⁻[(CH₃)₂NH₂]⁺ are excluded.

The cation [Kt]^(x+) of the compounds of the formula (1) according to the invention can stand for an organic or inorganic cation.

In the case of an inorganic cation, this is preferably a metal cation. Particular preference is given to an alkali-metal cation, preferably a lithium, potassium or sodium cation.

Compounds according to the invention having an inorganic cation are particularly suitable as starting materials for the synthesis of compounds according to the invention having organic cations, so-called ionic liquids, as described above.

Particular preference is therefore given to compounds of the formula (1) in which [Kt]^(x+) is an organic cation.

The organic cation is preferably selected from the group comprising ammonium, phosphonium, uronium, thiouronium, sulfonium, oxonium, guanidinium cations, heterocyclic cations and iminium cations, which are defined as described above.

[Kt]^(x+) of the compound of the formula (1) according to the invention is particularly preferably an organic cation which is selected from the group comprising imidazolium, pyridinium, pyrrolidinium, ammonium, phosphonium, sulfonium and iminium cations, as defined above.

The organic cations [Kt]^(x+) are very particularly preferably a cation selected from the group comprising phenylphosphonium, 1-ethyl-3-methylimidazolium, 1-butyl-3-methylimidazolium, N-hexylpyridinium and 1-butyl-2,3-dimethylimidazolium.

z in the compounds of the formula (1) according to the invention preferably stands for 2 or 3; z is particularly preferably =3.

In addition, n in formula (1) preferably stands for 2, 3 or 4, particularly preferably for 2 or 4. n very particularly preferably stands for 2.

The compounds of the formula (1) are particularly preferably selected from [Kt]^(x+)[(C₂F₅)₃PF₂H]⁻ _(x) or [Kt]^(x+)[(C₂F₅)₂PF₃H]⁻ _(x), in which [Kt]^(x+) stands for an organic cation selected from the group comprising ammonium, phosphonium, uronium, thiouronium, sulfonium, oxonium, guanidinium cations and heterocyclic cations, as defined above; the compounds are preferably selected from tetraphenylphosphonium difluorohydridotris(pentafluoroethyl)-phosphate, 1-ethyl-3-methylimidazolium difluorohydridotris(pentafluoroethyl)phosphate, 1-butyl-3-methylimidazolium difluorohydridotris(pentafluoroethyl)phosphate, N-hexylpyrridinium difluorohydridotris(pentafluoroethyl)phosphate, N-butyl-N-methylpyrrolidinium difluorohydridotris(pentafluoroethyl)phosphate and 1-butyl-2,3-dimethylimidazolium difluorohydridotris(pentafluoroethyl)phosphate.

As described above, the compounds according to the invention have many different properties which facilitate their use in various areas of application.

The following working examples are intended to explain the invention without limiting it. The invention can be carried out correspondingly throughout the entire range claimed. Possible variants can also be derived starting from the examples. In particular, the features and conditions of the reactions described in the examples can also be applied to other reactions which are not shown in detail, but fall within the scope of protection of the claims.

EXAMPLES Example 1 Tetraphenylphosphonium difluorohydridotris(pentafluoroethyl)phosphate

2.38 g (5.4 mmol) of (C₂F₅)₃PF₂ are slowly added at 0° C. to 5.6 ml of a one molar LiAlH₄/THF solution (5.6 mmol), and the mixture is stirred for 20 minutes. The solution is hydrolysed at 0° C. using water, giving a colourless precipitate (aluminium hydroxide), and 1.89 g (5.1 mmol) of [PPh4]Cl in 5 ml of chloroform are added. The precipitate is filtered off and washed with chloroform. The aqueous phase is separated off, and the chloroform phase is dried in vacuo, leaving a colourless precipitate.

Yield (based on [PPh₄]Cl): 3.18 g (78%)

Melting point: 114-116° C.

TABLE 1.1 ¹⁹F-NMR data of [PPh₄][P(C₂F₅)₃F₂H] in CDCl₃ δ [ppm] Multiplicity J [Hz] Assignment Integral −81.4 m — trans-CF₃ 1.6 −83.1 m — cis-CF₃ 3.3 −113.9 d, d, m ¹J_((PF)) = 737 PF 1 ²J_((FH)) = 58 −120.6 d, m ²J_((PF)) = 104 trans-CF₂ 1 −127.3 d, m ²J_((PF)) = 93 cis-CF₂ 2

TABLE 1.2 ³¹P-NMR data of [PPh₄][P(C₂F₅)₃F₂H] in CDCl₃ δ [ppm] Multiplicity J [Hz] Assignment Integral 23.4 s — [PPh₄][(C₂F₅)₃PF₂H] 1 −154.9 d, t, quin, t ¹J_((PF)) = 738 [PPh₄][(C₂F₅)₃PF₂H] 0.9 ²J_((PFtrans)) = 104 ²J_((PFcis)) = 93 ¹J_((PH)) = 678

TABLE 1.3 ¹H-NMR data of [PPh₄][P(C₂F₅)₃F₂H] in CDCl₃ δ [ppm] Multiplicity J [Hz] Assignment Integral 5.6 d, t, t, m ¹J_((PH)) = 678 [(C₂F₅)₃PF₂H]⁻ 1 ²J_((HF)) = 64 ³J_((HFtrans)) = 13 7.6-7.9 m — [P(C₆H₅)₄]⁺ 25

TABLE 1.4 Elemental analysis data C H calculated 47.01 2.76 experimental 47.15 2.87

TABLE 1.5 Mass-spectrometric data (EI, 20 eV) m/e Rel. intensity [%] Assignment 672 1 [PPh₃(C₂F₅)₃PFH]⁺ 628 0 [PPh₄(C₂F₅)₂PH]⁺ 596 2 [PPh₄(C₂F₅)(CF₃)PF₂]⁺ 566 1 [PPh₃(C₂F₅)₂PF₂]⁺ 551 0 [PPh₃(C₂F₅)₂PH]⁺ 520 2 [PPh₃(C₂F₅)(CF₃)PF₂]⁺ 490 4 [PPh₂(C₂F₅)₂PF₂]⁺ 444 2 [PPh(C₂F₅)(CF₃)PF₂]⁺ 414 13 [PPh(C₂F₅)₂PF₂]⁺ 355 6 [PPh₂(C₂F₅)PF]⁺ 337 53 [PPh₄]⁺ 277 7 [PPh(C₂F₅)PF]⁺ 262 100 [PPh₃]⁺ 183 23 [(C₂F₅)PFH]⁺ 108 7 [PPh]⁺ 78 9 [Ph]⁺

TABLE 1.6 ESI mass spectrum - negative scan mode Signal Rel. intensity [%] Assignment 307.18 19 [(C₂F₅)₂PF₂]⁻ 417.21 100 [(C₂F₅)₃PF₂H]⁻

Example 2 1-Ethyl-3-methylimidazolium difluorohydridotris-(penta-fluoroethyl)phosphate, [EMIM][P(C₂F₅)₃F₂H]

8.1 g (19 mmol) of (C₂F₅)₃PF₂ are slowly added at 0° C. to 20 ml of a one molar LiAlH₄/THF solution (20 mmol), and the mixture is stirred for 30 minutes. The solution is hydrolysed using water at 0° C., giving a colourless precipitate (aluminium hydroxide), and 2.8 g (19 mmol) of 1-ethyl-3-methylimidazolium chloride, dissolved in 2 ml of water, are added. After stirring for 30 minutes, the precipitate is filtered off. A second phase deposits, which is separated off and extracted twice with water. It is subsequently dried in vacuo, leaving a colourless liquid.

Yield (based on 1-ethyl-3-methylimidazolium chloride): 3.4 g (33%)

Analytical data of [EMIM][P(C₂F₅)₃F₂H]:

Melting point [° C.] −2.4 Decomposition [° C.] 176 H₂O content [ppm] 43 Cl⁻ content [ppm] <5 F⁻ content [ppm] 112

TABLE 2.1 ¹⁹F-NMR data of [EMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment Integral −81.1 m, d ⁴J_((FH)) = 1 trans-CF₃ 1 −82.3 quin, d ³J_((PF)) = 9 cis-CF₃ 2 ⁴J_((FH)) = 2 −114.1 d, d, m ¹J_((PF)) = 736 PF 0.7 ²J_((FH)) = 64 −119.7 d, m ² _((PF)) = 104 trans-CF₂ 0.6 −126.3 d, m ²J_((PF)) = 93 cis-CF₂ 1.2

TABLE 2.2 ³¹P-NMR data of [EMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment −154.4 d, t, quin, t ¹J_((PF)) = 735 [C₂F₅)₃PF₂H]⁻ ¹J_((PH)) = 678 ²J_((PFtrans)) = 104 ²J_((PFcis)) = 93

TABLE 2.3 ¹H-NMR data of [EMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment Integral 1.6 t ³J_((HH)) = 7 H7 3 4.0 s — H8 3 4.4 q ³J_((HH)) = 7 H6 2 5.7 d, t, t, m ¹J_((PH)) = 675 [(C₂F₅)₃PF₂H]⁻ 1 ²J_((HF)) = 63 ³J_((HFtrans)) = 13 7.7/7.8 t ³J_((HH)) = 2 H4/5 2 9.0 s — H2 1

TABLE 2.4 ¹³C{¹H}-NMR data of [EMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment 14.5 s — C7 35.6 s — C8 44.9 s — C6 119.9 m — —CF₂CF₃ 122.2 s — C5 122.9 m — —CF₂CF₃ 123.9 s — C4 136.2 s — C2 ^(a){¹H} ^(b){¹⁹F}

Example 3 1-Butyl-3-methylimidazolium difluorohydridotris(pentafluoroethyl)phosphate, [BMIM][P(C₂F₅)₃F₂H]

12.1 g (28.5 mmol) of (C₂F₅)₃PF₂ are slowly added at 0° C. to 30 ml of a one molar LiAlH₄/THF solution (30 mmol), and the mixture is stirred for 30 minutes. The solution is hydrolysed using water at 0° C., giving a colourless precipitate (aluminium hydroxide), and 4.9 g (28.5 mmol) of 1-butyl-3-methylimidazolium chloride in water are added. After stirring for 20 minutes, the precipitate is filtered off. A second phase deposits, which is separated off and extracted twice with water. It is subsequently dried in vacuo, leaving a colourless viscous liquid.

Yield (based on 1-butyl-3-methylimidazolium chloride): 10.2 g (64%)

Analytical data of [BMIM][P(C₂F₅)₃F₂H]:

Glass transition [° C.] −86 Cold crystallisation [° C.] −38 Melting point [° C.] −2.6 Decomposition [° C.] 177 H₂O content [ppm] 40 Cl⁻ content [ppm] <5 F⁻ content [ppm] 48

Viscosity and density of [BMIM][P(C₂F₅)₃F₂H]:

T [° C.] ν [mm²/s] ρ [g/cm³] 20 96.48 1.581 30 58.94 1.571 40 38.64 1.560 50 26.78 1.549 60 19.45 1.538 70 14.65 1.527 80 11.38 1.517

TABLE 3.1 ¹⁹F-NMR data of [BMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment Integral −80.8 m — trans-CF₃ 1 −81.9 m — cis-CF₃ 1.9 −115.0 d, d, m ¹J_((PF)) = 724 PF 0.6 ²J_((FH)) = 65 −119.1 d, m ²J_((PF)) = 107 trans-CF₂ 0.6 −125.7 d, m ²J_((PF)) = 92 cis-CF₂ 1.3

TABLE 3.2 ³¹P-NMR data of [BMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment −154.2 d, t, quin, t ¹J_((PF)) = 737 [C₂F₅)₃PF₂H]⁻ ¹J_((PH)) = 676 ²J_((PFtrans)) = 104 ²J_((PFcis)) = 94

TABLE 3.3 ¹H-NMR data of [BMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment Integral 0.9 t ³J_((HH)) = 7 H9 3.1 1.4 sext ³J_((HH)) = 8 H8 2.1 1.9 quin ³J_((HH)) = 7 H7 2.2 4.0 s — H10 3.1 4.4 t ³J_((HH)) = 8 H6 2 5.7 d, t, t, m ¹J_((PH)) = 675 [(C₂F₅)₃PF₂H]⁻ 0.6 ²J_((HF)) = 63 ³J_((HFtrans)) = 13 7.7 m ³J_((HH)) = 7 H4, H5 2 9.1 s — H2 1

TABLE 3.4 ¹³C{¹H}-NMR data of [BMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment 12.7 s — C9 19.0 s — C8 31.8 s — C7 35.7 s — C6 49.4 s — C10 118.9 m — —CF₂CF₃ 122.5 s — C4 122.9 m — —CF₂CF₃ 123.9 s — C5 136.4 s — C2 ^(a){¹H} ^(b){¹⁹F}

Example 4 N-Hexylpyrridinium difluorohydridotris(pentafluoroethyl)phosphate, [HPy][P(C₂F₅)₃F₂H]

12.14 g (28.5 mmol) of (C₂F₅)₃PF₂ are slowly added at 0° C. to 30 ml of a one molar LiAlH₄/THF solution (30 mmol), and the mixture is stirred for 30 minutes. The solution is hydrolysed using water at 0° C., giving a colourless precipitate (aluminium hydroxide), and 5.67 g (28.5 mmol) of N-hexylpyrridinium chloride, dissolved in 10 ml of water, are added. After stirring for 30 minutes, the precipitate is filtered off. The emulsion obtained is dried in vacuo. The cloudy, viscous residue is extracted three times with water and again dried in vacuo, leaving a colourless liquid.

Yield (based on N-hexylpyrridinium chloride): 9.98 g (59%)

Analytical data of [HPy][P(C₂F₅)₃F₂H]

Glass transition [° C.] −76 Decomposition [° C.] 166 H₂O content [ppm] 27 Cl⁻ content [ppm] 143

TABLE 4.1 ¹⁹F-NMR data of [HPy][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment Integral −79.9 m — trans-CF₃ 1 −81.1 m — cis-CF₃ 2 −112.9 d, d, m ¹J_((PF)) = 737 PF 0.6 ²J_((FH)) = 61 −118.6 d, m ²J_((PF)) = 105 trans-CF₂ 0.5 −125.2 d, m ²J_((PF)) = 92 cis-CF₂ 1.2

TABLE 4.2 ³¹P-NMR data of [HPy][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment −152.7 d, t, quin, t ¹J_((PF)) = 737 [C₂F₅)₃PF₂H]⁻ ¹J_((PH)) = 676 ²J_((PFtrans)) = 104 ²J_((PFcis)) = 94

TABLE 4.3 ¹H-NMR data of [HPy][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment Integral 0.9 m H12 3 1.3; 1.9 m H8-H11 9 4.5 t ³J_((HH)) = 7 H7 2 5.6 d, t, t, m ¹J_((PH)) = 673 [(C₂F₅)₃PF₂H]⁻ 1 ²J_((HF)) = 63 ³J_((HFtrans)) = 13 8.0 m — H3, H5 2 8.5 t ³J_((HH)) = 8 H4 1 8.7 d ³J_((HH)) = 6 H2, H6 2

TABLE 4.4 ¹³C-{¹H}-NMR data of [HPy][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment 13.1 s — C12 22.0 s — C11 25.2 s — C10 30.7 s — C9 30.8 s — C8 61.9 s — C7 118.2 m — —CF₂CF₃ 120.9 m — —CF₂CF₃ 128.4 s — C4 144.4 s — C3, C5 145.7 s — C2, C6 ^(a){¹H} ^(b){¹⁹F}

Example 5 1-Butyl-2,3-dimethylimidazolium difluorohydridotris(pentafluoroethyl)phosphate, [BMMIM][P(C₂F₅)₃F₂H]

12.1 g (28.5 mmol) of (C₂F₅)₃PF₂ are slowly added at 0° C. to 30 ml of a one molar LiAlH₄/THF solution (30 mmol), and the mixture is stirred for 30 minutes. The solution is hydrolysed using water at 0° C., giving a colourless precipitate (aluminium hydroxide), and 5.4 g (28.5 mmol) of 1-butyl-2,3-dimethylimidazolium chloride, dissolved in 2 ml of water, are added. After stirring for 20 minutes, the precipitate is filtered off. A second phase deposits, which is separated off and extracted twice with water. It is subsequently dried in vacuo, leaving a colourless liquid.

Yield (based on 1-butyl-2,3-dimethylimidazolium chloride): 9.1 g (55%)

Analytical data of [BMMIM][P(C₂F₅)₃F₂H]:

Glass transition [° C.] −78 Cold crystallisation [° C.] −24 Melting point [° C.] 9.6 Decomposition [° C.] 179 H₂O content [ppm] 122 Cl⁻ content [ppm] 6 F⁻ content [ppm] 198

TABLE 5.1 ¹⁹F-NMR data of [BMMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment Integral −79.9 m — trans-CF₃ 1 −81.1 m — cis-CF₃ 2 −112.9 d, d, m ¹J_((PF)) = 737 PF 0.7 ²J_((FH)) = 65 −118.6 d, m ²J_((PF)) = 105 trans-CF₂ 0.6 −125.1 d, m ²J_((PF)) = 95 cis-CF₂ 1.2

TABLE 5.2 ³¹P-NMR data of [BMMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment −153.7 d, t, quin, t ¹J_((PF)) = 737 [C₂F₅)₃PF₂H]⁻ ¹J_((PH)) = 674 ²J_((PFtrans)) = 104 ²J_((PFcis)) = 92

TABLE 5.3 ¹H-NMR data of [BMMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment Integral 1.0 t ³J_((HH)) = 7 H9 1.5 1.4 sext ³J_((HH)) = 7 H8 1 1.9 quin ³J_((HH)) = 7 H7 1 2.8 s — H11 1.5 3.9 s — H10 1.6 4.3 t ³J_((HH)) = 7 H6 1.1 5.7 d, t, t, m ¹J_((PH)) = 675 [(C₂F₅)₃PF₂H]⁻ — ²J_((HF)) = 63 ³J_((HFtrans)) = 13 7.6 m — H4, H5 1

TABLE 5.4 ¹³C-{¹H}-NMR data of [BMMIM][P(C₂F₅)₃F₂H] in acetone-d₆ δ [ppm] Multiplicity J [Hz] Assignment 8.9 s — C11 12.7 s — C9 19.1 s — C8 31.2 s — C7 34.6 s — C10 48.0 s — C6 120.8 s C4/5 122.2 s — C4/5 144.4 s — C2

Example 6 Hydrolysis of [EMIm][P(C₂F₅)₃F₂H]

0.72 g of [EMIm][P(C₂F₅)₃PF₂H] are stirred at 110° C. for 8 hours in 10 ml of H₂O. Volatile constituents are subsequently removed in vacuo, and the residue is investigated by NMR spectroscopy.

TABLE 6.1 ³¹P-NMR spectroscopic data of the residue in H₂O δ [ppm] Multiplicity J[Hz] Assignment 5.4 d, t ¹J_((PH)) = 586 (C₂F₅)PH(O)OH ²J_((PF)) = 80 2.3 quin ²J_((PF)) = 76 (C₂F₅)₂P(O)OH −3.5 t ²J_((PF)) = 78 (C₂F₅)P(O)(OH)₂

Example 7 Synthesis of [Me₂NCH₂NMe₃][P(C₂F₅)₃F₂H]

0.43 g (7.3 mmol) of trimethylamine, NMe₃, are condensed into 5.14 g (12.1 mmol) of tris(pentafluoethyl)difluorophosphorane, (C₂F₅)₃PF₂. The mixture is brought to room temperature, whereupon two phases can be observed. The mixture is subsequently stirred at room temperature for 24 hours. After a few hours, a colourless solid forms. After one day, volatile substances are removed in vacuo, leaving a colourless solid. Yield of the crude product (based on NMe₃) is virtually quantitative (1.99 g).

TABLE 7.1 ³¹P-NMR data of [(CH₃)₂NCH₂N(CH₃)₃][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment −153.7 d, t, quin, t ¹J_((PH)) = 674 [P(C₂F₅)₃F₂H]⁻ ¹J_((PF)) = 733 ²J_((PFcis)) = 94 ²J_((PFtrans)) = 104

TABLE 7.2 ¹⁹F-NMR data of [(CH₃)₂NCH₂N(CH₃)₃][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment Integral −80.6 m — trans-CF₃ 3 −81.8 m — cis-CF₃ 6 −113.6 d, d, m, ¹J_((PF)) = 733 PF 2 ²J_((FH)) = 62 −119.1 d, m ²J_((PFtrans)) = 104 trans-CF₂ 2 −125.7 d, m ²J_((PFcis)) = 94 cis-CF₂ 4

TABLE 7.3 ¹H-NMR spectroscopic data of [(CH₃)₂NCH₂N(CH₃)₃][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment Integral 2.6 s — (CH₃)₂N— 6 2.8 s — —N(CH₃)₃ 9 4.0 s — —NCH₂N— 2 5.7 d, t, m ¹J_((PH)) = 675 [P(C₂F₅)₃PF₂H]⁻ 1 ²J_((FH)) = 63

TABLE 7.4 ¹³C{¹H}-NMR spectroscopic data of [(CH₃)₂NCH₂N(CH₃)₃][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment Integral 45.3 s — (CH₃)₂N— 48.4 s — —N(CH₃)₃ 90.5 s — —NCH₂N—

Example 8 Reaction of N(C₂H₅)₃ with (C₂F₅)₃PF₂

0.92 g (9.07 mmol) of triethylamine, NEt₃, are added to 3.77 g (8.85 mmol) of tris(pentafluoethyl)difluorophosphorane, (C₂F₅)₃PF₂. The mixture is stirred at room temperature for 24 hours, during which it becomes an intense brown colour and becomes oily with solid components. Volatile constituents are removed in vacuo. Crude yield: 3.94 g. The crude product is dissolved in CH₂Cl₂, and the product, [(C₂H₅)₃NH]—[P(C₂F₅)₃F₂H], is brought to crystallisation at −28° C.

IR(ATR): v(NH) 3203 cm⁻¹

TABLE 8.1 ³¹P-NMR data of [(C₂H₅)₃NH][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment −152.6 d, t, quin, t ¹J_((PH)) = 681 [P(C₂F₅)₃F₂H]⁻ ¹J_((PF)) = 723 ²J_((PFtrans)) = 107 ²J_((PFcis)) = 92

TABLE 8.2 ¹⁹F-NMR data of [(C₂H₅)₃NH][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment Integral −81.0 m — trans-CF₃ 3 −82.2 “quin”, d 8.5/1 cis-CF₃ 6 −115.3 d, d, m ¹J_((PF)) = 719 [P(C₂F₅)₃F₂H]⁻ 2 ²J_((HF)) = 62 −119.2 d, m ²J_((PF)) = 107 trans-CF₂ 2 −125.8 d, m ²J_((PF)) = 95 cis-CF₂ ([P(C₂F₅)₃F₂H]⁻) 4

TABLE 8.3 ¹H-NMR data of [(C₂H₅)₃NH][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment Integral 1.3 t ³J_((HH)) = 7 —CH₃ 9 3.2 quar ³J_((HH)) = 7 —CH₂— 6 5.7 d, quin, t, m ¹J_((PH)) = 645 [P(C₂F₅)₃F₂H]⁻ 1 ³J_((FH)) = 13 ³J_((FH)) = 2

TABLE 8.4 ¹³C{¹H}-NMR data of [(C₂H₅)₃NH][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment 8.2 s — —CH₃ 47.0 s — —CH₂—

Example 9 Reaction of HN(C₂H₅)₂ with (C₂F₅)₃PF₂

0.60 g (8.25 mmol) of diethylamine, HNEt₂, are added to 3.44 g (8.08 mmol) of tris(pentafluoethyl)difluorophosphorane, (C₂F₅)₃PF₂. The mixture is stirred at room temperature for 24 hours, during which it becomes an intense brown colour. Volatile constituents are removed in vacuo. Crude yield: 3.18 g.

The crude product is dissolved in CH₂Cl₂, and the product, [(C₂H₅)₂NH₂]-[P(C₂F₅)₃F₂H], is brought to crystallisation at −28° C.

TABLE 9.1 ³¹P-NMR data of [(C₂H₅)₂NH₂][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment −153.2 d, t, quin, t ¹J_((PH)) = 679 [P(C₂F₅)₃F₂H]⁻ ¹J_((PF)) = 721 ²J_((PFcis)) = 92 ²J_((PFtrans)) = 106

TABLE 9.2 ¹⁹F-NMR data of [(C₂H₅)₂NH₂][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment Integral −81.5 m — trans-CF₃ — −82.8 m — cis-CF₃ — −114.9 d, d, m ¹J_((PF)) = 722 [P(C₂F₅)₃F₂H]⁻ 2 ²J_((HF)) = 65 −119.3 d, m ²J_((PFtrans)) = 105 trans-CF₂ 2 −126.0 d, m ²J_((PFcis)) = 92 cis-CF₂ 4

TABLE 9.3 ¹H-NMR data of [(C₂H₅)₂NH₂][P(C₂F₅)₃F₂H] in CD₂Cl₂ δ, ppm Multiplicity J/Hz Assignment Integral 1.4 t 7 —CH₃ 1.5 3.1 quar 7 —CH₂— 1 5.8 d, t, quin, m ¹J_((PH)) = 681 [P(C₂F₅)₃F₂H]⁻ 0.15 ²J_((HF)) = 63 ³J_((HFcis)) = 14

TABLE 9.4 ¹³C{¹H}-NMR data of [(C₂H₅)₂NH₂][P(C₂F₅)₃F₂H] in CD₂Cl₂ δ, ppm Multiplicity J/Hz Assignment 10.9 s — —CH₃ 43.6 s — —CH₂—

Example 10 Reaction of Me₂NCH₂NMe₂ with (C₂F₅)₃PF₂

4.5 g (10.6 mmol) of tris(pentafluoethyl)difluorophosphorane, (C₂F₅)₃PF₂, are added at room temperature to 0.88 g (8.6 mmol) of Me₂NCH₂NMe₂. Two phases can be observed. The mixture is stirred for 24 hours, during which a yellow emulsion forms. Excess (C₂F₅)₃PF₂ is removed in vacuo, and the residue is investigated by NMR spectroscopy.

IR(ATR): v(NH) 3202 cm⁻¹

TABLE 10.1 ³¹P-NMR data of the [P(C₂F₅)₃F₂H] anion in CD₃CN δ, ppm Multiplicity J/Hz Assignment −154.1 d, t, quin, m ¹J_((PH)) = 678 [P(C₂F₅)₃F₂H]⁻ ¹J_((PF)) = 730 ²J_((PFcis)) = 93

TABLE 10.2 ¹⁹F-NMR data of the [P(C₂F₅)₃F₂H] anion in CD₃CN δ, ppm Multiplicity J/Hz Assignment −81.1 m — trans-CF₃ −82.4 m — cis-CF₃ −113.2 d, d, m ¹J_((PF)) = 724 [P(C₂F₅)₃F₂H]⁻ ²J_((HF)) = 68 −119.3 d, m ²J_((PFtrans)) = 118 trans-CF₂ −125.7 d, m ²J_((PFcis)) = 94 cis-CF₂

Example 11 Reaction of i-(C₃H₇)₂NCH₃ with (C₂F₅)₃PF₂

0.82 g (7.12 mmol) of N,N-diisopropylmethylamine are dissolved in 50 ml of diethyl ether, and 3.03 g (7.0 mmol) of tris(pentafluoethyl)difluorophosphorane, (C₂F₅)₃PF₂, are added at room temperature. The mixture is stirred for four days and subsequently freed from volatile substances in vacuo, leaving a brown solid, which is purified by recrystallisation from CH₂Cl₂ at −28° C., leaving a colourless solid. Yield: 2.61 g.

TABLE 11.1 ³¹P-NMR data of [((CH₃)₂CH)₂N(H)CH₃][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment −154.4 d, t, quin, t ¹J_((PH)) = 675 [P(C₂F₅)₃F₂H]⁻ ¹J_((PF)) = 733 ²J_((PFtrans)) = 104 ²J_((PFcis)) = 94

TABLE 11.2 ¹⁹F-NMR data of [((CH₃)₂CH)₂N(H)CH₃][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment Integral −81.3 m — trans-CF₃ 3 −82.5 m — cis-CF₃ 6 −114.3 d, d, m ¹J_((PF)) = 734 [P(C₂F₅)₃F₂H]⁻ 2 ²J_((HF)) = 63 −119.8 d, m ²J_((PFtrans)) = trans-CF₂ 2 105 −126.5 d, m ²J_((PFcis)) = 93 cis-CF₂ 4

TABLE 11.3 ¹H-NMR data of [((CH₃)₂CH)₂N(H)CH₃][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment Integral 1.5 d ³J_((HH)) = 7 —CH(CH₃)₂ 1 2.8 s —NCH₃ 0.2 3.7 sept ³J_((HH)) = 7 —CH(CH₃)₂ 0.15 5.7 d, t, quin, m ¹J_((PH)) = 680 [P(C₂F₅)₃F₂H] 0.15 ²J_((HF)) = 64 ³J_((HFcis)) = 13

TABLE 11.4 ¹³C{¹H}-NMR data of [((CH₃)₂CH)₂N(H)CH₃][P(C₂F₅)₃F₂H] in CD₃CN δ, ppm Multiplicity J/Hz Assignment 19.3 s — CH₃ 32.3 s — NCH₃ 56.8 s — NCH

Example 12 Reaction of [Me₂NCH₂NMe₃][P(C₂F₅)₃F₂H] with (PhO)₂P(O)H

[(CH₃)₂NCH₂N(CH₃)₃][(C₂F₅)₃PF₂H]+(C₆H₅O)₂P(O)H→(CH₃)₂NCH₂P(O)(OC₆H₅)₂+[HN(CH₃)₃][(C₂F₅)₃PF₂H]

[Me₂NCH₂NMe₃][P(C₂F₅)₃F₂H] is dissolved in CH₂Cl₂, and an excess of (PhO)₂PHO is added. The solution is investigated by NMR spectroscopy.

TABLE 12.1 ³¹P-NMR data of the products in CH₂Cl₂ δ, ppm Multiplicity J/Hz Assignment 7.3 t ²J_((PCH2)) = 13 Me₂NCH₂P(O)(OPh)₂ −153.8 d, t, quin, t ¹J_((PH)) = 678 [P(C₂F₅)₃F₂H]⁻ ¹J_((PF)) = 731 ²J_((PFtrans)) = 104 ²J_((PFcis)) = 93

TABLE 12.2 ¹³C{¹H}-NMR data of the products in CH₂Cl₂ δ, ppm Multiplicity J/Hz Assignment 44.7 s — HN(CH₃)₃ ⁺ 45.1 d ³J_((PC)) = 5 (CH₃)₂NCH₂P(O)(OPh)₂ 51.4 d ¹J_((PC)) = 157 (CH₃)₂NCH₂P(O)(OPh)₂

Example 13 Reaction of [Me₂NCH₂NMe₃][P(C₂F₅)₃F₂H] with P(CH₃)₃

[Me₂NCH₂NMe₃][P(C₂F₅)₃F₂H] is dissolved in CH₂Cl₂, and excess P(CH₃)₃ is condensed on. The solution is investigated by NMR spectroscopy.

TABLE 13.1 ³¹P-NMR data of [(CH₃)₂NCH₂P(CH₃)₃][P(C₂F₅)₃F₂H] in CH₂Cl₂ δ, ppm Multiplicity J/Hz Assignment 24.3 dec, t ²J_((PCH3)) = 13 [(CH₃)₂NCH₂P(CH₃)₃]⁺ ²J_((PCH2)) = 4 ¹J_((PC)) = 54 −154.1 d, t, quin, t ¹J_((PH)) = 678 [P(C₂F₅)₃F₂H]⁻ ¹J_((PF)) = 728 ²J_((PFtrans)) = 105 ²J_((PFcis)) = 93

TABLE 13.2 ¹⁹F-NMR data of [(CH₃)₂NCH₂P(CH₃)₃][P(C₂F₅)₃F₂H] in CH₂Cl₂ δ, ppm Multiplicity J/Hz Assignment Integral −80.8 m — trans-CF₃ 3 −82.0 m — cis-CF₃ 6 −113.9 d, d, m ¹J_((PF)) = 730 PF 2 ²J_((FH)) = 63 −119.2 d, m ²J_((PFtrans)) = 105 trans-CF₂ 2 −125.7 d, m ²J_((PFcis)) = 93 cis-CF₂ 4

TABLE 13.3 ¹H-NMR data of [(CH₃)₂NCH₂P(CH₃)₃][P(C₂F₅)₃F₂H] in CH₂Cl₂ δ, ppm Multiplicity J/Hz Assignment Integral 1.8 d ²J_((PH)) = 14 [(CH₃)₂NCH₂P(CH₃)₃]⁺ 9 2.4 s — [(CH₃)₂NCH₂P(CH₃)₃]⁺ 6 3.3 d ²J_((PH)) = 5 [(CH₃)₂NCH₂P(CH₃)₃]⁺ 2

TABLE 13.4 ¹³C{¹H}-NMR data of [(CH₃)₂NCH₂P(CH₃)₃][P(C₂F₅)₃F₂H] in CH₂Cl₂ δ, ppm Multiplicity J/Hz Assignment 6.5 d ¹J_((PC)) = 54 [(CH₃)₂NCH₂P(CH₃)₃]⁺ 47.6 d ³J_((PC)) = 7 [(CH₃)₂NCH₂P(CH₃)₃]⁺ 51.6 s (br) — N(CH₃)₃ 52.9 d ¹J_((PC)) = 7 [(CH₃)₂NCH₂P(CH₃)₃]⁺ 

The invention claimed is:
 1. A process for the preparation of a compound of formula (1) [Kt]^(x+)[(C_(n)F_(2n+1))_(Z)PF_(5-z)H]⁻ _(x),  (1) in which [Kt]^(x+) is an inorganic or organic cation, n is 1-8, x is 1-4, and z is 1-4, said process comprising: in a first step, reacting a compound of formula (2) (C_(n)F_(2n+1))_(z)PF_(5-z)  (2) with a hydride ion donor, and if [Kt]^(x+) in formula (1) is an organic cation, in a second step, optionally reacting the product from said first step with a compound of formula (3) [Kt]^(x+)[X]⁻ _(x),  (3), in which [Kt]^(x+) stands for an organic cation and [X]⁻ stands for a hydrophilic anion.
 2. The process according to claim 1, wherein said hydride ion donor is selected from metal hydrides, borohydrides, hydridoborates, hydridoaluminates and tertiary and secondary amines.
 3. The process according to claim 2, wherein said hydride ion donor is LiAlH₄.
 4. The process according to claim 2, wherein said hydride ion donor is a tertiary or secondary amine of formula (11) R¹⁴ ₂N—CH₂R¹⁵  (11), where R¹⁴ and R¹⁵ on each occurrence, independently of one another, denotes H, where a maximum of one substituent R¹⁴ can be H, straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, where R¹⁵ may also be Cl or F, where R¹⁵ may be fully substituted by fluorine and/or one or more R¹⁴ and/or R¹⁵ may be partially substituted by halogens or partially substituted by —OR^(1*), —NR^(1*) ₂, —CN, —C(O)NR^(1*) ₂ or —SO₂NR^(1*) ₂, and where one or two non-adjacent carbon atoms which are not in the α-position of the radicals R¹⁴ and/or R¹⁵ are each optionally replaced by atoms and/or atom groups selected from —O—, —S—, —S(O)—, —SO₂—, —N⁺R^(1*) ₂—, —C(O)NR^(1*)—, —SO₂NR^(1*)— and —P(O)R^(1*)—; and R^(1*) is a non- or partially fluorinated C₁- to C₆-alkyl, C₃- to C₇-cycloalkyl, unsubstituted or substituted phenyl.
 5. The process according to claim 1, wherein z stands for 2 or
 3. 6. The process according to claim 1, wherein [Kt]^(x+) is a metal cation.
 7. The process according to claim 1, wherein [Kt]^(x+) is an organic cation.
 8. The process according to claim 7, wherein the cation [Kt]^(x+) is selected from ammonium, phosphonium, uronium, thiouronium, sulfonium, oxonium, guanidinium cations, heterocyclic cations and iminium cations, where ammonium cations are given by formula (4) [NR₄]⁺  (4), where R in each case, independently of one another, denotes H, straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, where one R may be fully substituted by fluorine and/or one or more R may be partially substituted by halogens or partially substituted by —OR¹, —NR^(1*) ₂, —CN, —C(O)NR¹ ₂ or —SO₂NR¹ ₂, and where one or two non-adjacent carbon atoms which are not in the α-position of the radical R are each optionally replaced by atoms and/or atom groups selected —O—, S, S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹— and —P(O)R¹—; where phosphonium cations are given by formula (5) [PR² ₄]⁺  (5), where R² in each case, independently of one another, denotes H where all substituents R² cannot simultaneously be H, NR¹ ₂, straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, where one R² may be fully substituted by fluorine and/or one or more R² may be partially substituted by halogens, or partially substituted by —OR¹, —CN, —C(O)NR¹ ₂, or —SO₂NR¹ ₂, and where one or two non-adjacent carbon atoms which are not in the α-position of the R² are each optionally replaced by atoms and/or atom groups selected from —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, and —P(O)R¹—; where uronium cations are given by formula (6) [C(NR³R⁴)(OR⁵)(NR⁶R⁷)]⁺  (6) and thiouronium cations are given by formula (7) [C(NR³R⁴)(SR⁵)(NR⁶R⁷)]⁺  (7), where R³ to R⁷ each, independently of one another, denote H, NR^(1*) ₂, straight-chain or branched alkyl having 1 to 20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, where one or more of the substituents R³ to R⁷ may be partially substituted by halogens, or by —OH, —OR¹, —CN, —C(O)NR¹ ₂, or —SO₂NR¹ ₂, and where one or two non-adjacent carbon atoms which are not in the α-position of R³ to R⁷ are each optionally replaced by atoms and/or atom groups selected from —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, and —P(O)R¹—; where sulfonium cations are given by formula (12)) [(R^(o) ₃S]⁺  (12), where R^(o)stands for NR′″₂, straight-chain or branched alkyl having 1-8 C atoms, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, where one or more of the substituents R⁰ may be partially substituted by halogens, or by —OR′″, —CN or —N(R′″)₂; where oxonium cations are given by formula (13) [(R^(o*))₃O]⁺  (13), where R^(o*) stands for straight-chain or branched alkyl having 1-8 C atoms, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, where one or more of the substituents R^(0*) may be partially substituted by halogens, or by —OR′″, —CN or —N(R′″)₂; where guanidinium cations are given by formula (8) [C(NR⁸R⁹)(NR¹⁰R¹¹)(NR¹²R¹³)]+  (8), where R⁸ to R¹³ each, independently of one another, denote H, NR^(1*) ₂, straight-chain or branched alkyl having 1 to 20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, where one or more of the substituents R⁸ to R¹³ may be partially substituted by halogens or by —OR¹, —CN, —C(O)NR¹ ₂, or —SO₂NR¹ ₂, and where one or two non-adjacent carbon atoms which are not in the α-position of R⁸ to R¹³ are each optionally replaced by atoms and/or atom groups selected from —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, and —P(O)R¹—; where heterocyclic cations are given by formula (9) [HetN]⁺  (9), where [HetN]⁺ is a heterocyclic cation selected from

where the substituents R^(1′) to R^(4′) each, independently of one another, denote H, straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, saturated, partially or fully unsaturated heteroaryl, heteroaryl-C₁-C₆-alkyl or aryl-C₁-C₆-alkyl, where the substituents R^(1′), R^(2′), R^(3′) and/or R^(4′) together may form a ring system, where one or more substituents R^(1′) to R^(4′) may be partially or fully substituted by halogens or partially substituted by —OR¹, —CN, —C(O)NR¹ ₂, or —SO₂NR¹ ₂, but where R^(1′) and R^(4′) cannot simultaneously be fully substituted by halogens, and where one or two non-adjacent carbon atoms which are not bonded to the heteroatom of the substituents R^(1′) to R^(4′)are each optionally replaced by atoms and/or atom groups selected from —O—, —S—, —S(O)—, —SO₂—, —N⁺R¹ ₂—, —C(O)NR¹—, —SO₂NR¹—, and —P(O)R¹—; and where iminium cations are given by formula (10) [R¹⁴ ₂N═CHR¹⁵]⁺  (10), where R¹⁴ and R¹⁵ on each occurrence, independently of one another, denotes H, where a maximum of one substituent R¹⁴ can be H, straight-chain or branched alkyl having 1-20 C atoms, straight-chain or branched alkenyl having 2-20 C atoms and one or more double bonds, straight-chain or branched alkynyl having 2-20 C atoms and one or more triple bonds, saturated, partially or fully unsaturated cycloalkyl having 3-7 C atoms, which may be substituted by alkyl groups having 1-6 C atoms, where R¹⁵ may also stand for Cl or F, where R¹⁵ may be fully substituted by fluorine and/or one or more R¹⁴ and/or R¹⁵ may be partially substituted by halogens or partially substituted by —OR^(1*), —NR^(1*) ₂, —CN, —C(O)NR^(1*) ₂ or —SO₂NR^(1*) ₂, and where one or two non-adjacent carbon atoms which are not in the α-position of the radical R¹⁴ and/or R¹⁵ are each optionally replaced by atoms and/or atom groups selected from —O—, —S—, —S(O)—, —N⁺R^(1*) ₂—, —C(O)NR^(1*)—, —SO₂NR^(1*)— and —P(O)R^(1*)—; in which R¹ stands for H, non- or partially fluorinated C₁- to C₆-alkyl, C₃- to C₇-cycloalkyl, unsubstituted or substituted phenyl, R^(1*) stands for non- or partially fluorinated C₁- to C₆-alkyl, C₃- to C₇-cycloalkyl, unsubstituted or substituted phenyl, and R′″ stands for a straight-chain or branched C₁-C₈-alkyl.
 9. The process according to claim 1, wherein the reaction in the first step is carried out at −80 to 50° C.
 10. A process comprising reacting a compound of formula (1) [Kt]^(x+)[(c_(n)F_(2n+1))_(z)PF_(5-z)H]⁻ _(x)  (1) in which [Kt]^(x+) is an inorganic cation, n is 1-8, x is 1-4, and z is 1-4, with a compound of formula (3) [Kt]^(x+)[X]⁻ _(x)  (3), in which [Kt]^(x+) is an organic cation and [X]⁻ stands for a hydrophilic anion.
 11. An electrolyte composition comprising a compound of formula (1) [Kt]^(x+)[(C_(n)F_(2n+1))_(z)PF_(5-z)H]⁻ _(x)  (1) in which [Kt]^(x+)is an organic cation, n is 1-8, x is 1-4, and z is 1-4.
 12. A compound of formula (1) [Kt]^(x+)[(C_(n)F_(2n+1))_(z)PF_(5-z)H]⁻ _(x)  (1) in which [Kt]^(x+) is an inorganic or organic cation, n is 1-8, x is 1-4, and z is 1-4, where the compounds [(CF₃)₂PF₃H]⁻K⁺, [(CF₃)₂PF₃H]⁻[(CH₃)₂NH₂]⁺, [(CF₃)PF₄H]⁻K⁺ and [(CF₃)PF₄H]⁻[(CH₃)₂NH₂]⁺are excluded.
 13. A compound according to claim 12, wherein [Kt]^(x+) is a metal cation.
 14. A compound according to claim 12, wherein [Kt]^(x+) is an organic cation.
 15. A process comprising: converting a compound according to claim 1, in which [Kt]^(x+) stands for an organic cation, into a compound containing a [(C_(n)F_(2n+1))₂P(O)O]⁻ or [(C_(n)F_(2n+1))P(O)O₂]⁻² anion by hydrolysis.
 16. The process according to claim 1, wherein the product from said first step is reacted with a compound of formula (3) to obtain a compound of formula (1) in which [Kt]^(x+) stands for an organic cation.
 17. The process according to claim 1, wherein said hydride ion donor is a metal hydride and the product from said first step is reacted with a compound of formula (3) to obtain a compound of formula (1) in which [Kt]^(x+) stands for an organic cation.
 18. The process according to claim 1, wherein n stands for 2, 3 or
 4. 19. The process according to claim 5, wherein n stands for 2, 3 or
 4. 20. The process according to claim 1, wherein compound of formula (2) is (C₂F₅)₃PF₂.
 21. The process according to claim 1, wherein [Kt]^(x+) is an inorganic cation which is a metal cation selected from lithium, sodium, and potassium cations.
 22. The process according to claim 1, wherein [Kt]^(x+) is an organic cation selected from propyl(dimethyl)ethylammonium, methoxyethyl(dimethyl)ethylammonium, 1-butyl-1-methylpyrrolidinium, 1-propyl-1-methylpyrrolidinium, 1-methoxyethyl-1-methylpyrrolidinium, 1-ethyl-3-methylimidazolium, 1-butyl-3-methylimidazolium and 1-methyl-3-propylimidazolium.
 23. The process according to claim 1, wherein [Kt]^(x+) is an organic cation selected from 1-ethyl-3-methylimidazolium and 1-butyl-3-methylimidazolium.
 24. The process according to claim 16, wherein [X]⁻ is an anion selected from Cl⁻, Br⁻, I⁻, sulfate, sulfonate, acetate and BF₄ ⁻.
 25. The process according to claim 1, wherein the reaction in the first step is carried out at a temperature of −80 to 50° C. in the presence of an aprotic solvent.
 26. The process according to claim 25, wherein said aprotic solvent is dioxane, tetrahydrofuran, diethyl ether, methyl tert-butyl ether, hexane, cyclohexane, benzene, dichloromethane or dichloroethane.
 27. The process according to claim 16, wherein the reaction in the second step is carried out at room temperature in the presence of water or in a mixture of water and organic solvent. 